Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...

Chips seeded with the astronauts’ bone marrow cells circled the moon to help probe how deep-space flight affects human ...

FY2025 revenue up 24%, margins expanding, backlog growing, and 25% upside to $13.05. Read the full analysis here.

Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene ...

Postdoctoral training is a defining stage in a scientist’s career, offering the mentored research experience and professional ...

MastCURe, a high-profile research consortium, has been awarded EUR1.3M in funding from the Eureka Eurostars program. The collaboration comprising Allegria Therapeutics, Cube Biotech, and the ...

MastCURe, a high-profile research consortium, has been awarded €1.3M in funding from the Eureka Eurostars program. The ...

The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading ...

Beyond moon photos, NASA's AVATAR experiment on Artemis II uses astronaut blood samples on chips to study and solve space's ...

The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading ...

Launched on April 1, 2026, Artemis II is a historic approximately 10-day lunar flyby mission that is sending four astronauts farther into space than any humans have traveled since the Apollo era, ...